|
High $0.02 |
Low $0.02 |
Trades 56 |
Turnover $22,520 |
Volume 1,033,118 |
| 30 June 2023 at 3:59pm | ||||
|
Market Cap (13-Nov) $13,536,492 (791st) |
Close (30-Jun) $0.022 |
Volume (30-Jun) 1,033,118 |
Shortsold (7-Aug) 1,552,633 (0.26%) (384th) |
|
52w High $0.048 |
52w Low $0.012 |
P/E 84.75 |
EPS 0 |
A$1.9m contract - South Africa HIV Self-Test private market
AT1 released this announcement to the ASX on 5 April 2023, 9:28. The announcement is marked as price sensitive, and is 2 page(s) in length and 146.89kb in size.
You can view all announcements from AT1 and see how they appear on a price chart on the announcements page.
At the date of this announcement, AT1 was 0.100% short sold according to ASIC data. It was ranked the 461st most shorted stock on the ASX. It is now ranked as the 384th most shorted stock on the ASX with 0.256% of total shares short sold as of the latest reported data (07 August 2023).
| Other Recent Announcements from AT1 | |
|---|---|
| Ceasing to be a substantial holder | 23 June 2023, 16:26 |
| Exclusive Agreement for HIV Testing Signed with Newfoundland | 14 June 2023, 9:54 |
| Change in substantial holding | 6 June 2023, 18:02 |
| A$1.9m contract - South Africa HIV Self-Test private market | 5 April 2023, 9:28 |
| Ceasing to be a substantial holder | 20 March 2023, 18:11 |
| Significant Purchase Order for HIV Self-Tests for Europe | 28 February 2023, 8:57 |
| Atomo H1 FY23 Results Presentation | 23 February 2023, 8:06 |
If you were already registered, log in here.